General MedicationsOTICStandard
CIPROFLOXACIN AND DEXAMETHASONE
CIPROFLOXACIN; DEXAMETHASONE
Standard Dose
0.3%;0.1%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview CIPROFLOXACIN AND DEXAMETHASONE is listed in Drugs@FDA under application 216501 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN; DEXAMETHASONE Form and strength SUSPENSION/DROPS;OTIC - 0.3%;0.1% Sponsor AMNEAL Submission history Latest submission status date: 2024-03-22 00:00:00.
Structured Monograph
Clinical summary
Approval overview CIPROFLOXACIN AND DEXAMETHASONE is listed in Drugs@FDA under application 216501 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient CIPROFLOXACIN; DEXAMETHASONE Form and strength SUSPENSION/DROPS;OTIC - 0.3%;0.1% Sponsor AMNEAL Submission history Latest submission status date: 2024-03-22 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.